Similar articles

• Neuroleptic drugs and dopamine receptors.

  Strange PG. Strange PG. Am J Psychiatry. 1991 Aug;148(8):1101. doi: 10.1176/ajp.148.8.1101a. Am J Psychiatry. 1991. PMID: 1677238 No abstract available.
• Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.

  Snyder SH, Largent BL. Snyder SH, et al. J Neuropsychiatry Clin Neurosci. 1989 Winter;1(1):7-15. doi: 10.1176/jnp.1.1.7. J Neuropsychiatry Clin Neurosci. 1989. PMID: 2577720 Review.
• Pharmacology of N-desmethylclozapine.

  Lameh J, Burstein ES, Taylor E, Weiner DM, Vanover KE, Bonhaus DW. Lameh J, et al. Pharmacol Ther. 2007 Aug;115(2):223-31. doi: 10.1016/j.pharmthera.2007.05.004. Epub 2007 May 21. Pharmacol Ther. 2007. PMID: 17583355 Review.
• [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].

  Lideman RR, Zlobina GP, Mukhin AG. Lideman RR, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1980;80(5):762-9. Zh Nevropatol Psikhiatr Im S S Korsakova. 1980. PMID: 6106337 Review. Russian. No abstract available.
• Down-regulation of central dopamine receptors in schizophrenia.

  Zemlan FP, Hitzemann RJ, Hirschowitz J, Garver DL. Zemlan FP, et al. Am J Psychiatry. 1985 Nov;142(11):1334-7. doi: 10.1176/ajp.142.11.1334. Am J Psychiatry. 1985. PMID: 2865903